Browsing by Subject "Isoniazid"
Now showing items 1-3 of 3
-
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
(PLoS One, 2011)RATIONALE: Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. ... -
Reply to Swindells et al.: Trials of Tuberculosis-Preventive Therapy in People with HIV Infection.
(American journal of respiratory and critical care medicine, 2020-07) -
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
(PLoS One, 2012)BACKGROUND: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment ...
